CD11b+ Gr1+ bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Clinical trials and animal models suggest that infusion of bone marrow cells (BMCs) is effective therapy for liver fibrosis, but the underlying mechanisms are obscure, especially those associated with early effects of BMCs. Here, we analyzed the early impact of BMC infusion and identified the subsets of BMCs showing antifibrotic effects in mice with carbon tetrachloride–induced liver fibrosis. An interaction between BMCs and activated hepatic stellate cells (HSCs) was investigated using an in vitro coculturing system. Within 24 hours, infused BMCs were in close contact with activated HSCs, which was associated with reduced liver fibrosis, enhanced hepatic expression of interleukin (IL)-10, and expanded regulatory T cells but decreased macrophage infiltration in the liver at 24 hours after BMC infusion. In contrast, IL-10–deficient (IL-10−/−) BMCs failed to reproduce these effects in fibrotic livers. Intriguingly, in isolated cells, CD11b+Gr1highF4/80− and CD11b+Gr1+F4/80+ BMCs expressed more IL-10 after coculturing with activated HSCs, leading to suppressed expression of collagen and α-smooth muscle actin in HSCs. Moreover, these effects were either enhanced or abrogated, respectively, when BMCs were cocultured with IL-6−/− and retinaldehyde dehydrogenase 1−/− HSCs. Similar to murine data, human BMCs expressed more IL-10 after coculturing with human HSC lines (LX-2 or hTERT), and serum IL-10 levels were significantly elevated in patients with liver cirrhosis after autologous BMC infusion. Conclusion : Activated HSCs increase IL-10 expression in BMCs (CD11b+Gr1highF4/80− and CD11b+Gr1+F4/80+ cells), which in turn ameliorates liver fibrosis. Our findings could enhance the design of BMC therapy for liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., & Cheroutre, H. (2007) · Science · doi:10.1126/science.1145697 · Cited by 1,982 · cited 2×
“In addition, the antagonist effect of retinoic acid on IL-6 has been demonstrated during T cell differentiation.(8) However the underlying mechanism is not clear.”
BackgroundPathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Self-citationHuang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435 · cited 4×
“Infused BMC-Derived IL-10 Is a Key Molecule for Ameliorating Liver Fibrosis and Expansion of Liver Tregs.”
MethodInfluentialSinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., & Ostrand-Rosenberg, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.977 · Cited by 847
Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M. P., Greten, T. F., & Korangy, F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.020 · Cited by 793 · cited 3×
“Infused BMC-Derived IL-10 Is a Key Molecule for Ameliorating Liver Fibrosis and Expansion of Liver Tregs.”
MethodKarlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782 · cited 1×
“In contrast, CD11bþF4/80þGr1þ macrophages promote liver fibrosis and tumor development in a TGF-b–dependent manner.(32,33) These reports”
BackgroundRadaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z., & Gao, B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.055 · Cited by 610
Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses
Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P. A., Modlin, R. L., Liblau, R. S., Gressner, A. M., & Kaufmann, S. H. E. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.011 · Cited by 410
Thomas, J. A., Pope, C., Wojtacha, D., Robson, A. J., Gordon-Walker, T. T., Hartland, S., Ramachandran, P., Van Deemter, M., Hume, D. A., Iredale, J. P., et al. (2011) · Hepatology · doi:10.1002/hep.24315 · Cited by 346 · cited 1×
“For instance, delivery of bone marrow–derived macrophages differentiated by colony-stimulating factor-1 are reportedly beneficial by reducing fibrosis, mainly by recruiting endogenous macrophages and neutrophils producing matrix metalloproteinase (MMP)-9 and MMP-13; however, this protective effect was not detected in…”
BackgroundDendritic Cell Regulation of Carbon Tetrachloride–Induced Murine Liver Fibrosis Regression
Jiao, J., Sastre, D., Fiel, M. I., Lee, U. E., Ghiassi–Nejad, Z., Ginhoux, F., Vivier, E., Friedman, S. L., Merad, M., & Aloman, C. (2012) · Hepatology · doi:10.1002/hep.24621 · Cited by 154
Self-citation
Cited by
Wen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613
The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways
Zhang, K., Han, X., Zhang, Z., Zheng, L., Hu, Z., Yao, Q., Cui, H., Shu, G., Si, M., Li, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00204-4 · Cited by 242
Hyun, J., Wang, S., Kim, J., Rao, K. M., Park, S. Y., Chung, I., Ha, C.-S., Kim, S.-W., Yun, Y. H., & Jung, Y. (2016) · Nature Communications · doi:10.1038/ncomms10993 · Cited by 219
Self-citationSeo, W., Eun, H. S., Kim, S. Y., Yi, H., Lee, Y., Park, S., Jang, M., Jo, E., Kim, S. C., Han, Y., et al. (2016) · Hepatology · doi:10.1002/hep.28644 · Cited by 175
Self-citationMechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview
Pinheiro, D., Dias, I., Ribeiro Silva, K., Stumbo, A. C., Thole, A., Cortez, E., de Carvalho, L., Weiskirchen, R., & Carvalho, S. (2019) · Cells · doi:10.3390/cells8111339 · Cited by 46
(2017) · Experimental and Clinical Transplantation · doi:10.6002/ect.2016.0226 · Cited by 14
Pinheiro, D., Leirós, L., Dáu, J. B. T., Stumbo, A. C., Thole, A. A., Cortez, E. A. C., Mandarim-de-Lacerda, C. A., Carvalho, L. D., & Carvalho, S. N. D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187970 · Cited by 13
Precise cell therapy for liver fibrosis: Endothelial cell and macrophage therapy
Deng, L., Wu, B., Liang, K., Liao, H., & Du, Y. (2022) · iLIVER · doi:10.1016/j.iliver.2022.11.002 · Cited by 4
Metadata
- Authors
- Suh, Y.-G., Kim, J. K., Byun, J.-S., Yi, H.-S., Lee, Y.-S., Eun, H. S., Kim, S. Y., Han, K.-H., Lee, K. S., Duester, G., Friedman, S. L., & Jeong, W.-I.
- Venue
- Hepatology
- Published
- 2012-11
- Volume
- 56
- Issue
- 5
- Pages
- 1902-1912
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2073387472
- Cited by
- 74
- References
- 12
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.